New York Life Investment Management LLC Harmony Biosciences Holdings, Inc. Transaction History

New York Life Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$29.93 - $35.06 $14,306 - $16,758	478 Added 4.48%	11,136 $373,000
Q4 2023 Feb 05, 2024	SELL	$19.2 - $33.78 $4,742 - $8,343	-247 Reduced 2.27%	10,658 $344,000
Q3 2023 Nov 07, 2023	SELL	$31.89 - $39.03 $54,787 - $67,053	-1,718 Reduced 13.61%	10,905 $357,000
Q2 2023 Aug 04, 2023	SELL	$30.5 - $37.4 $46,909 - $57,521	-1,538 Reduced 10.86%	12,623 $444,000
Q1 2023 May 08, 2023	BUY	$30.8 - $53.92 $436,158 - $763,561	14,161 New	14,161 $462,000

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.